Best Options Strategy for RCKT
Looking for the best options strategy for Rocket Pharmaceuticals, Inc. (RCKT)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live RCKT option chain right now, and a simple map from your view on RCKT to the strategy that fits it. Model any of them in the calculator before you trade.
About RCKT
Rocket Pharmaceuticals, Inc. (RCKT) is a major company in Biotechnology. Options traders on RCKT tend to watch , since these can drive large moves in the share price.
About Rocket Pharmaceuticals, Inc.
# About Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals is a biotechnology company in the advanced stages of development focused on gene therapies for rare genetic disorders. The company works with two main technological platforms: in vivo adeno-associated viral vectors and ex vivo lentiviral vectors. On the viral side, it is developing treatments for several inherited cardiac conditions—Danon disease (currently in Phase 2 trials), plakophilin-2 arrhythmogenic cardiomyopathy (Phase 1), and BAG3 dilated cardiomyopathy (preclinical)—all of which cause progressive heart damage and life-threatening complications. The lentiviral program targets blood and immune disorders including leukocyte adhesion deficiency, Fanconi anemia, and pyruvate kinase deficiency, where gene correction aims to restore defective cell production or immune function.
Revenue generation remains limited at this stage, as most candidates are still in clinical trials and none have reached commercialization. The company operates primarily in the United States and has established licensing partnerships with several research institutions and universities, including UCL Business and the University of California,…
Today's top-scoring strategy for RCKT
Our engine ranks defined-risk strategies on the live RCKT chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Sell | 1× | CALL | $3 | $0.17 |
| Buy | 1× | CALL | $4 | $0.01 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $4 | −$70 | −$68 | −$66 | −$65 | −$63 |
| $4 | −$57 | −$56 | −$55 | −$54 | −$53 |
| $4 | −$43 | −$42 | −$42 | −$41 | −$41 |
| $3 | −$27 | −$27 | −$27 | −$27 | −$28 |
| $3 | −$12 | −$12 | −$13 | −$14 | −$14 |
| $3 | $2 | $1 | −$0 | −$2 | −$3 |
| $3 | $11 | $10 | $9 | $7 | $6 |
| $3 | $15 | $15 | $14 | $13 | $12 |
| $3 | $16 | $16 | $16 | $15 | $15 |
| $2 | $16 | $16 | $16 | $16 | $16 |
| $2 | $16 | $16 | $16 | $16 | $16 |
Illustrative example at RCKT's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
RCKT is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 32% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on RCKT currently price in about 32% implied volatility, versus roughly 54% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
Off that volatility, the options market is pricing a move of about ±$0.24 (±8%) in RCKT by 2026-08-21 — a range of roughly $2.88 to $3.36. Strikes inside that band hold most of the premium and see most of the action.
RCKT insider trading activity (SEC Form 4)
Open-market insider transactions at RCKT over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Shah Gaurav | Sell | 55,684 | $172K | 2026-05-21 |
| Shah Gaurav | Sell | 2,409 | $7K | 2026-05-19 |
| Wilson Martin | Sell | 662 | $2K | 2026-05-19 |
| Militello John | Sell | 384 | $1K | 2026-05-19 |
| Shah Gaurav | Sell | 2,728 | $10K | 2026-05-13 |
| Wilson Martin | Sell | 3,361 | $12K | 2026-05-13 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Earnings & IV crush
RCKT's next earnings report is due around November 5, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $379M
- Beta (vs market)
- 0.47
- 52-week range
- $2.53–$5.45 (20% up the range)
- Short interest
- 18.6% of float · 5.5 days to cover
With 18.6% of RCKT's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for RCKT
Start with your outlook on RCKT, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while RCKT stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open RCKT in the free calculator →
Frequently asked questions
What is the best options strategy for RCKT?
It depends on your outlook. Bullish traders often use a long call or bull call spread on RCKT; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are RCKT options liquid enough to trade?
Rocket Pharmaceuticals, Inc. (RCKT) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade RCKT options?
Buying a single RCKT call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade RCKT or any security. Do your own research.
What does Rocket Pharmaceuticals, Inc. do?
Rocket Pharmaceuticals, Inc. (RCKT) operates in the Biotechnology industry. The "About Rocket Pharmaceuticals, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Rocket Pharmaceuticals, Inc. pay a dividend?
We don't show a confirmed dividend yield for Rocket Pharmaceuticals, Inc. here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Rocket Pharmaceuticals, Inc. next report earnings?
Rocket Pharmaceuticals, Inc.'s next earnings are expected around November 5, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to RCKT
Comparing RCKT with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 9 Cedarbrook Drive, Cranbury, NJ, 08512, United States
- Industry
- Biotechnology
- Employees
- 202
- CEO
- Dr. Gaurav D. Shah M.D.
- Phone
- 609 659 8001
- Website
- www.rocketpharma.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.